- This event has passed.
NEW
BFG ON NORTHROP GRUMMAN’S NG-20 CYGNUS CARGO MISSION (ISS Natl Lab), Jan 26, 2024, virtual, 1:00 pm ET
Event Navigation
The ISS National Lab will host a webinar on January 26, 2024 at 1:00 pm ET to discuss research that will be delivered to the International Space Station by Northrop Grumman’s Cygnus spacecraft on the NG-20 mission scheduled for launch on January 29, 2024 at 12:29 pm ET.
The webinar will be livestreamed. More information is on the ISS National Lab website. It also will be webcast on NASA TV.
Participants are (updated January 26):
- Lisa Carnell, director, NASA’s Biological and Physical Sciences Division
- Meg Everett, deputy scientist, NASA’s International Space Station Program
- Shane Farritor, co-founder and chief scientific officer of Virtual Incision Corporation, will discuss NASA’s Robotic Surgery Tech Demo, which will test techniques for performing robotic surgery in microgravity using a miniature surgical robot that can be remotely controlled or teleoperated from Earth.
- Mark Fernandez, principal investigator of Spaceborne Computer-2 at Hewlett Packard Enterprise (HPE), will discuss the continued development of its commercial off-the-shelf high-performance computer system that can operate in the harsh conditions of space.
- Mary Murphy, director of programs at Nanoracks, a Voyager Space company, will introduce the GITAI (GEE-tie) Extravehicular Robotics Demonstration, which aims to showcase the versatility and dexterity of GITAI’s robotic systems in microgravity.
- Michael Roberts, chief scientific officer, International Space Station National Lab
- Nicole Wagner, chief executive officer of LambdaVision, will discuss the company’s latest investigation to advance efforts to manufacture artificial retinas in space. This will mark the ninth investigation from LambdaVision to explore in-space manufacturing capabilities.
- Abba Zubair, medical director of the Mayo Clinic, will discuss a NASA investigation aiming to use microgravity to cultivate clinical-grade stem cells for therapeutic applications in humans. The Mayo Clinic has supported multiple spaceflight missions seeking to leverage microgravity to further medical advancements for patient care on Earth and beyond.